Nortadalafil

CAS No. 171596-36-4

Nortadalafil( Demethyl Tadalafil )

Catalog No. M20552 CAS No. 171596-36-4

Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 65 In Stock
10MG 102 In Stock
25MG 192 In Stock
50MG 335 In Stock
100MG 537 In Stock
200MG 762 In Stock
500MG 1134 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nortadalafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
  • Description
    Nortadalafil is demethyl Tadalafil which is a PDE5 inhibitor treating erectile dysfunction (ED) ; and under the name Adcirca for the treatment of pulmonary arterial hypertensio.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Demethyl Tadalafil
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    171596-36-4
  • Formula Weight
    375.38
  • Molecular Formula
    C21H16N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (133.20 mM)
  • SMILES
    O=C1CNC(=O)[C@H]2Cc3c([nH]c4ccccc34)[C@H](N12)c1ccc2OCOc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takahiro R Nakamura S Kohno H et al. Contribution of CYP3A Isoforms to Dealkylation of PDE5 Inhibitors: A Comparison between Sildenafil N-Demethylation and Tadalafil Demethylenation[J]. Biological & Pharmaceutical Bulletin 2015 38(1):58-65.
molnova catalog
related products
  • Mirodenafil dihydroc...

    Mirodenafil dihydrochloride is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.

  • TPN171

    TPN171 is potent PDE5 inhibitor with subnanomolar potency for PDE5 and good selectivity over PDE6, which has the potential for the treatment of pulmonary arterial hypertension (PAH).

  • NSP-805

    NSP-805 is a potent and selective guinea pig cardiac phosphodiesterase 3 (PDE3) inhibitor.